Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

Lee Ratner; Thomas A. Waldmann; Murali Janakiram; Jonathan E. Brammer

doi:10.1056/NEJMc1803181

Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

Lee Ratner, Thomas A. Waldmann, Murali Janakiram, Jonathan E. Brammer

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	1947-1948
Number of pages	2
Journal	New England Journal of Medicine
Volume	378
Issue number	20
DOIs	https://doi.org/10.1056/NEJMc1803181
State	Published - May 17 2018
Externally published	Yes

Bibliographical note

Funding Information:
Supported by a Memorial Sloan Kettering Cancer Center core grant (P30 CA008748) and the Draper Family Fund. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1056/NEJMc1803181

OpenUrl availability

Full text

Cite this

@article{a7c008f3b7744fb18b5c41a21be9b00b,

title = "Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy",

author = "Lee Ratner and Waldmann, {Thomas A.} and Murali Janakiram and Brammer, {Jonathan E.}",

note = "Funding Information: Supported by a Memorial Sloan Kettering Cancer Center core grant (P30 CA008748) and the Draper Family Fund. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.",

year = "2018",

month = may,

day = "17",

doi = "10.1056/NEJMc1803181",

language = "English (US)",

volume = "378",

pages = "1947--1948",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "20",

}

TY - JOUR

T1 - Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

AU - Ratner, Lee

AU - Waldmann, Thomas A.

AU - Janakiram, Murali

AU - Brammer, Jonathan E.

N1 - Funding Information: Supported by a Memorial Sloan Kettering Cancer Center core grant (P30 CA008748) and the Draper Family Fund. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.

PY - 2018/5/17

Y1 - 2018/5/17

UR - http://www.scopus.com/inward/record.url?scp=85047177942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047177942&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1803181

DO - 10.1056/NEJMc1803181

M3 - Article

C2 - 29768155

AN - SCOPUS:85047177942

SN - 0028-4793

VL - 378

SP - 1947

EP - 1948

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 20

ER -

Rapid progression of adult T-cell leukemia–lymphoma after PD-1 inhibitor therapy

Bibliographical note

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this